惠泰醫療(688617.SH):一次性使用磁電定位壓力監測脈衝電場消融導管取得醫療器械註冊證
格隆匯12月18日丨惠泰醫療(688617.SH)公佈,2024年12月17日,公司全資子公司湖南埃普特醫療器械有限公司取得一項醫療器械註冊證,產品名稱:一次性使用磁電定位壓力監測脈衝電場消融導管,該產品在醫療機構中使用,與上海宏桐實業有限公司的心臟脈衝電場消融儀(型號:PFG-micro1、軟件發佈版本V1)配合使用,需與公司生產的一次性使用心臟脈衝電場消融導管共同使用,用於治療藥物難治性、複發性、症狀性陣發性房顫。其中一次性使用心臟脈衝電場消融導管用於肺靜脈口和前庭消融,本產品用於補充消融。本產品與上海宏桐實業有限公司生產的三維心臟電生理標測系統(型號:HT-9000Pro,軟件發佈版本V2)配合使用,提供導管在心內的位置信息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.